Quick Answer
Inhibrx Biosciences, Inc. reported Shares Outstanding of 14.58 million shares for fiscal year 2025.
Inhibrx Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 14.58M | +0.7% |
| 2024 | 14.48M | +0.0% |
| 2024 | 14.48M | -69.4% |
| 2023 | 47.37M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 14.50M | +0.2% | +0.2% |
| June 30, 2025 | 14.48M | +0.0% | +0.0% |
| March 31, 2025 | 14.48M | — | +0.0% |
| December 31, 2024 | 14.48M | -69.4% | +0.0% |
| September 30, 2024 | 14.48M | — | +0.0% |
| June 30, 2024 | 14.48M | — | +0.0% |
| May 31, 2024 | 14.48M | — | -69.4% |
| December 31, 2023 | 47.37M | — | — |
- Inhibrx Biosciences, Inc. showed an increase of +0.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, Inhibrx Biosciences, Inc.’s shares outstanding has declined by 69.2% (from 47.37 million shares to 14.58 million shares).
- The most recent figure is from Inhibrx Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: